164 related articles for article (PubMed ID: 8759187)
21. "Big IGF-II"-induced hypoglycemia secondary to gastric adenocarcinoma.
Morbois-Trabut L; Maillot F; De Widerspach-Thor A; Lamisse F; Couet C
Diabetes Metab; 2004 Jun; 30(3):276-9. PubMed ID: 15223980
[TBL] [Abstract][Full Text] [Related]
22. Prevention with glucocorticoids of extrapancreatic tumour-hypoglycaemia as a result of increased 'big' insulin-like growth factor II.
Föger B; Zapf J; Lechleitner M; Konwalinka G; Patsch JR
J Intern Med; 1994 Dec; 236(6):692-3. PubMed ID: 7989907
[No Abstract] [Full Text] [Related]
23. In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy.
Ferone D; Pivonello R; Lastoria S; Faggiano A; Del Basso de Caro ML; Cappabianca P; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2001 Apr; 54(4):469-77. PubMed ID: 11318782
[TBL] [Abstract][Full Text] [Related]
24. Non-islet cell tumour hypoglycaemia.
Krishnan L; Clark J
BMJ Case Rep; 2011 Jun; 2011():. PubMed ID: 22693317
[TBL] [Abstract][Full Text] [Related]
25. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
Frystyk J; Skjaerbaek C; Zapf J; Orskov H
Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
[TBL] [Abstract][Full Text] [Related]
26. Localization of metastatic gastroenteropancreatic tumours by somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-octreotide.
Hammond PJ; Arka A; Peters AM; Bloom SR; Gilbey SG
Q J Med; 1994 Feb; 87(2):83-8. PubMed ID: 8153292
[TBL] [Abstract][Full Text] [Related]
27. Non-islet cell tumour hypoglycaemia in a patient with a gastrointestinal stromal tumour.
Rikhof B; Van Den Berg G; Van Der Graaf WT
Acta Oncol; 2005; 44(7):764-6. PubMed ID: 16227170
[No Abstract] [Full Text] [Related]
28. [Insulin-like growth factor-II secreting prostate tumour causing severe hypoglycaemi].
Vadász J; Barta G; Krasznai G; Ludger F; Zalatnai A
Orv Hetil; 2014 Aug; 155(33):1319-24. PubMed ID: 25109918
[TBL] [Abstract][Full Text] [Related]
29. [Preoperative treatment of hypoglycemia caused by an insulinoma with the somatostatin analog SMS 201-995].
Sánchez García Cervigón P; Fernández Navarro JI; Salmerón de Diego J; Caballero Asensi A; Cornelio Hernández F; Jara Albarrán A
Med Clin (Barc); 1987 Oct; 89(12):511-3. PubMed ID: 2890800
[No Abstract] [Full Text] [Related]
30. Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.
Jannin A; Espiard S; Benomar K; Do Cao C; Mycinski B; Porte H; D'Herbomez M; Penel N; Vantyghem MC
Ann Endocrinol (Paris); 2019 Feb; 80(1):21-25. PubMed ID: 29555080
[TBL] [Abstract][Full Text] [Related]
31. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
Breeman WA; Hofland LJ; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Visser TJ; Lamberts SW
Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
[TBL] [Abstract][Full Text] [Related]
32. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma.
Hoekman K; van Doorn J; Gloudemans T; Maassen JA; Schuller AG; Pinedo HM
Clin Endocrinol (Oxf); 1999 Aug; 51(2):247-53. PubMed ID: 10468998
[TBL] [Abstract][Full Text] [Related]
33. Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo.
Duet M; Ajzenberg C; Benelhadj S; Lajeunie E; Lormeau B; Guillausseau PJ; Rohmer V; Vilain D; Mundler O; Warnet A
J Nucl Med; 1999 Aug; 40(8):1252-6. PubMed ID: 10450674
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous hypoglycaemia in a noninsulin-dependent diabetes mellitus patient with disseminated pancreatic carcinoma.
Sturrock ND; Selby C; Hosking DJ
Diabet Med; 1997 Apr; 14(4):324-6. PubMed ID: 9113488
[TBL] [Abstract][Full Text] [Related]
35. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6.
Bond JJ; Meka S; Baxter RC
J Endocrinol; 2000 May; 165(2):253-60. PubMed ID: 10810289
[TBL] [Abstract][Full Text] [Related]
36. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.
Becker W; Marienhagen J; Scheubel R; Saptogino A; Bakker WH; Breeman WA; Wolf F
Eur J Nucl Med; 1991; 18(11):924-7. PubMed ID: 1684323
[TBL] [Abstract][Full Text] [Related]
37. Solitary fibrous tumour of the liver with IGF-II-related hypoglycaemia. A case report.
Famà F; Le Bouc Y; Barrande G; Villeneuve A; Berry MG; Pidoto RR; Saint Marc O
Langenbecks Arch Surg; 2008 Jul; 393(4):611-6. PubMed ID: 18418627
[TBL] [Abstract][Full Text] [Related]
38. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.
Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia.
Baxter RC; Holman SR; Corbould A; Stranks S; Ho PJ; Braund W
J Clin Endocrinol Metab; 1995 Sep; 80(9):2700-8. PubMed ID: 7545698
[TBL] [Abstract][Full Text] [Related]
40. Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: dynamic endocrine studies and treatment with the somatostatin analogue octreotide.
Garcia MB; Koppeschaar HP; Lips CJ; Thijssen JH; Krenning EP
J Endocrinol Invest; 1994 Jan; 17(1):59-65. PubMed ID: 7911814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
